Interstitial Lung Disease Caused by Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

被引：0
|
作者：
del Castillo-Acuna, Rocio [1 ]
Serradilla, Ana [2 ,3 ]
Lopez-Campos, Fernando [4 ]
Counago, Felipe [5 ,6 ]
机构：
[1] Hosp Univ Punta Europa, Dept Radiat Oncol, Algeciras, Spain
[2] Complejo Hosp Jaen, Dept Radiat Oncol, Jaen, Spain
[3] Hosp Univ Ramon & Cajal, Dept Radiat Oncol, Madrid, Spain
[4] Hosp San Francisco Asis, Dept Radiat Oncol GenesisCare, Madrid, Spain
[5] Hosp Vithas La Milagrosa, Dept Radiat Oncol GenesisCare, Madrid, Spain
[6] GenesisCare Espana, Nacl Clin & Invest, Madrid, Spain
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2024年 / 60卷 / 08期
关键词：
D O I：
10.1016/j.arbres.2024.04.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [21] Charting a course in metastatic castration-sensitive prostate cancer
    Madan, Ravi A.
    Dahut, William L.
    NATURE REVIEWS UROLOGY, 2015, 12 (07) : 368 - 369
  • [22] Treatment Options in Metastatic Castration-Sensitive Prostate Cancer
    Choudhury, Atish D.
    ONCOLOGY-NEW YORK, 2022, 36 (03): : 184 - 185
  • [23] Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis
    Santoni, Matteo
    Massari, Francesco
    Rizzo, Alessandro
    Mollica, Veronica
    Cimadamore, Alessia
    Montironi, Rodolfo
    Battelli, Nicola
    TUMORI JOURNAL, 2023, 109 (02): : 157 - 163
  • [24] Transcriptomic Heterogeneity of Metastatic Disease Timing within Metastatic Castration-Sensitive Prostate Cancer
    Sutera, P.
    Shetty, A.
    Hakansson, A.
    Van der Eecken, K.
    Song, Y.
    Liu, Y.
    Fonteyne, V.
    Verbeke, S.
    Song, D.
    Ross, A. E.
    Feng, F. Y.
    Gillessen, S.
    Attard, G.
    James, N.
    Lotan, T. L.
    Davicioni, E.
    Sweeney, C.
    Tran, P. T.
    Deek, M. P.
    Ost, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E261 - E262
  • [25] Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide
    Lowentritt, Benjamin H.
    Du, Shawn
    Rossi, Carmine
    Muser, Erik
    Khilfeh, Ibrahim
    Kinkead, Frederic
    Korsiak, Jill
    Lefebvre, Patrick
    Pilon, Dominic
    Agarwal, Neeraj
    FUTURE ONCOLOGY, 2024, 20 (27) : 2005 - 2013
  • [26] How We Treat Metastatic Castration-Sensitive Prostate Cancer
    Ionescu, Filip
    Zhang, Jingsong
    CANCER CONTROL, 2024, 31
  • [27] Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Fizazi, Karim
    NamPhuong Tran
    Fein, Luis
    Matsubara, Nobuaki
    Rodriguez-Antolin, Alfredo
    Alekseev, Boris Y.
    Ozguroglu, Mustafa
    Ye, Dingwei
    Feyerabend, Susan
    Protheroe, Andrew
    De Porre, Peter
    Kheoh, Thian
    Park, Youn C.
    Todd, Mary B.
    Chi, Kim N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04): : 352 - 360
  • [28] Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
    Sutera, P. A.
    Shetty, A. C.
    Hakansson, A.
    Van der Eecken, K.
    Song, Y.
    Liu, Y.
    Chang, J.
    Fonteyne, V.
    Mendes, A. A.
    Lumen, N.
    Delrue, L.
    Verbeke, S.
    De Man, K.
    Rana, Z.
    Hodges, T.
    Hamid, A.
    Roberts, N.
    Song, D. Y.
    Pienta, K.
    Ross, A. E.
    Feng, F.
    Joniau, S.
    Spratt, D.
    Gillessen, S.
    Attard, G.
    James, N. D.
    Lotan, T.
    Davicioni, E.
    Sweeney, C.
    Tran, P. T.
    Deek, M. P.
    Ost, P.
    ANNALS OF ONCOLOGY, 2023, 34 (07) : 605 - 614
  • [29] Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!
    Messina, Carlo
    Messina, Marco
    Boccardo, Francesco
    EUROPEAN UROLOGY, 2018, 73 (01) : 147 - 148
  • [30] Rezvilutamide for metastatic castration-sensitive prostate cancer: CHART trial
    Singh, Kirti
    INDIAN JOURNAL OF UROLOGY, 2023, 39 (02) : 171 - 172
12345